[Static contrast sensitivity in idiopathic Parkinson disease]

Area of Science:

• Neuroscience
• Ophthalmology
• Clinical Neurology

Background:

• Parkinson's disease (PD) is associated with visual dysfunctions, specifically impaired contrast sensitivity (C.S.).
• The precise mechanisms and dopaminergic influence on C.S. deficits in PD require further elucidation.

Purpose of the Study:

• To investigate static contrast sensitivity (C.S.) in patients with Parkinson's disease.
• To explore the relationship between C.S. and dopaminergic function in PD.
• To evaluate the utility of the Colored Stripes Electronic Generator (GEPCO) for monitoring visual defects in PD.

Main Methods:

• Contrast sensitivity (C.S.) was assessed in 12 Parkinson's disease patients and 12 healthy controls using the Colored Stripes Electronic Generator (GEPCO).
• A subset of three PD patients underwent repeat testing to observe changes over time and in response to treatment.

Main Results:

• Parkinson's disease patients exhibited a general C.S. deficiency across spatial frequencies, most notably at intermediate frequencies.
• Two of three re-tested PD patients showed C.S. deterioration correlating with disease progression.
• One patient demonstrated improved C.S. following the initiation of dopaminergic therapy (dopatherapy).

Conclusions:

• Static contrast sensitivity (C.S.) is significantly impaired in Parkinson's disease and is influenced by dopaminergic pathways.
• C.S. deterioration in PD may stem from functional failures in the visual cortex and retina.
• The GEPCO test offers a reproducible method for monitoring visual sensory deficits and treatment response in Parkinson's disease patients.